These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 902534)

  • 1. [Factor XIII deficiency in burns].
    Burkhardt H; Zellner PR; Möller I
    Chirurg; 1977 Aug; 48(8):520-3. PubMed ID: 902534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor XIII].
    Takahashi I; Fukue H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():660-2. PubMed ID: 15658417
    [No Abstract]   [Full Text] [Related]  

  • 6. Postoperative bleeding in a patient with normal screening coagulation tests.
    Nourbakhsh E; Anvari R; D'cunha N; Thaxton L; Malik A; Nugent K
    Am J Med Sci; 2011 Sep; 342(3):262-4. PubMed ID: 21804371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features of congenital factor XIII deficiency.
    Al-Sharif FZ; Aljurf MD; Al-Momen AM; Ajlan AM; Musa MO; Al-Nounou RM; Al-Mohareb FI; Alomar HM; Zaidi ZZ; Al-Zahrani HA
    Saudi Med J; 2002 May; 23(5):552-4. PubMed ID: 12070580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of factor XIII analysis in blood coagulation tests].
    Yorifuji H; Ikematsu S
    Nihon Rinsho; 1989 Dec; 48 Suppl():846-8. PubMed ID: 2622017
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
    Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
    Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation disorders due to burns. Disseminated intravascular coagulation (DIC) and its possible prevention].
    Bréan L; Bormioli M; Angela GC; Ferrari F
    Minerva Med; 1975 Aug; 66(55):2729-42. PubMed ID: 1161170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
    Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of HUMF13A01 (AAAG)n STR polymorphism to the genetic diagnosis of coagulation factor XIII deficiency.
    Kangsadalampai S; Coggan M; Caglayan SH; Aktuglu G; Board PG
    Thromb Haemost; 1996 Dec; 76(6):879-82. PubMed ID: 8972004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
    Asahina T; Kobayashi T; Takeuchi K; Kanayama N
    Obstet Gynecol Surv; 2007 Apr; 62(4):255-60. PubMed ID: 17371605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII deficiency mistaken for battered child syndrome: case of "correct" test ordering negated by a commonly accepted qualitative test with limited negative predictive value.
    Newman RS; Jalili M; Kolls BJ; Dietrich R
    Am J Hematol; 2002 Dec; 71(4):328-30. PubMed ID: 12447966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Hemorrhagic diseases due to insufficiency of coagulation factor XIII].
    Camerini G
    Minerva Pediatr; 1973 Dec; 25(43):1969-76. PubMed ID: 4779969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intracerebral hemorrhage associated with long-lasting deficiency of factor XIII].
    Nakajima M; Nakazawa T; Matsuda M; Handa J; Hayami M; Miyamoto Y; Ohta S
    No Shinkei Geka; 1999 May; 27(5):465-8. PubMed ID: 10363259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.